Abbvie Pty Ltd
Transforming Lives
We inspire hope and transform lives every day. We make decisions based on our
deep caring and compassion for people, delivering a lasting impact to our
patients, their families, our employees and the community.
• In 2022, Abbvie supplied 3057 Australian patients with compassionate
access to on-label non-reimbursed products.
• 30+ conditions treated across infants, adolescents, adults & seniors.
• 90,000+ Australians are treated with AbbVie’s products every year.
Our Science Impacts Lives
Clinical research is a key component of developing new medicines. Our scientists
are leveraging the latest technologies and scientific advances to discover and
develop new medicines.
• There are 1,600+ Australian patients currently participating in our trials.
• In Australia we are testing 34 active compounds in 114 active trials with
1,318 active patients.
• An additional 80+ new studies are planned in the next two years.
• $26.5 million invested in clinical research across Australia in 2022
ARA NSW-ACT 2024